Lee B Y, Horwitz M A
Division of Infectious Diseases, Department of Medicine, University of California at Los Angeles School of Medicine, Los Angeles, California 90095-1688, USA.
Infect Immun. 1999 May;67(5):2665-70. doi: 10.1128/IAI.67.5.2665-2670.1999.
The three most abundant extracellular proteins of Mycobacterium tuberculosis, the 30-, 32-, and 16-kDa major extracellular proteins, are particularly promising vaccine candidates. We have mapped T-cell epitopes of these three proteins in outbred guinea pigs by immunizing the animals with each protein and assaying splenic lymphocyte proliferation against a series of overlapping synthetic peptides covering the entire length of the mature proteins. The 30-kDa protein contained nine immunodominant epitopes, the 32-kDa protein contained two immunodominant epitopes, and the 16-kDa protein contained a highly immunodominant region at its N terminus. The immunodominant epitopes of the 30- and 32-kDa proteins in outbred guinea pigs were frequently identified in healthy purified-protein-derivative-positive or BCG-vaccinated individuals in previous studies. The immunodominant epitopes of these major extracellular proteins have potential utility in an epitope-based vaccine against tuberculosis.
结核分枝杆菌的三种最丰富的细胞外蛋白,即30 kDa、32 kDa和16 kDa的主要细胞外蛋白,是特别有前景的疫苗候选物。我们通过用每种蛋白免疫远交豚鼠,并检测脾淋巴细胞针对覆盖成熟蛋白全长的一系列重叠合成肽的增殖情况,在远交豚鼠中绘制了这三种蛋白的T细胞表位。30 kDa蛋白包含9个免疫显性表位,32 kDa蛋白包含2个免疫显性表位,16 kDa蛋白在其N端包含一个高度免疫显性区域。在先前的研究中,远交豚鼠中30 kDa和32 kDa蛋白的免疫显性表位在健康的纯化蛋白衍生物阳性或卡介苗接种个体中经常被鉴定出来。这些主要细胞外蛋白的免疫显性表位在基于表位的抗结核疫苗中具有潜在用途。